Search results for: “1 5”

  • CPIC® Guideline for Beta-blockers and CYP2D6, ADRB1, ADRB2, GRK4, and GRK5

    This guideline is in progress

  • NUDT15 CPIC guidelines

    CPIC guideline for thiopurines based on TPMT and NUDT15 gentoype   For gene-specific information tables (i.e. NUDT15 allele definition, allele functionality, frequency and diplotype-phenotype tables) see guideline pages or PharmGKB.

  • CPIC® Guideline for Thiopurines and TPMT and NUDT15

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium Guidelines for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 Update (November 2018) Updates since publication: March 2024: At the time of guideline publication, the extent of dosage reduction for thiopurines recommended for patients with intermediate metabolism for both TPMT and NUDT15 was unclear. A recent publication…

  • 2015 Conference Call Minutes

    CPIC in person meeting survey resutls cpic minutes nov 2015 CPIC Term Standardization and LOINC 151203 DIGITizE Overview Hicks presentation minutes cpic Apr 2015 minutes cpic August 2015 minutes cpic February 2015 minutes cpic Jan 2015 minutes cpic July 2015 minutes cpic june 2015 minutes cpic Mar 2015 minutes cpic May 2015 minutes cpic Oct…

  • Conference Call Minutes Nov 2015

    This is an example of what conference call minute posting could look like. AOITemplate

  • CPIC® Guideline for Serotonin Reuptake Inhibitor Antidepressants and CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants (April 2023) Updates since publication: None Tables provided in the main manuscript of the guideline: Table 1. Assignment of predicted phenotypes based on diplotypes Table 2. Dosing recommendations for antidepressants based on…

  • CPIC® guideline for statins and SLCO1B1, ABCG2, and CYP2C9

    Most recent guideline publication: The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms (January 2022) Updates since publication: none Tables provided in the main manuscript of the guideline: Table 1. Assignment of predicted SLCO1B1, ABCG2, and CYP2C9 likely phenotype based on genotype Table 2. Dosing recommendations for statins…

  • 2021 CPIC Conference Call Minutes

    January 2021 February 2021 Member survey results March 2021 Relling slides April 2021 Huddart slides May 2021 Caudle slides June 2021 July 2021 September 2021 Pratt slides Roden slides October 2021 Whirl-Carrillo slides (PharmCAT) November 2021 Relling slides December 2021 McLeod and Swen slides

  • CPIC® Guideline for Aminoglycosides and MT-RNR1

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for MT-RNR1 and Aminoglycosides (May 2021) Updates since publication: March 2023: This update to the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides in individuals with the MT-RNR1 genotype was precipitated following contact from primary care physicians and pediatricians. These clinicians had asked…

  • CPIC® Guideline for Proton Pump Inhibitors and CYP2C19

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (August 2020) Updates since publication: No updates on dosing recommendations since publication. Tables provided in the main manuscript of the guideline: Table 1. Assignment of predicted CYP2C19 phenotype based on genotype Table 2. Dosing recommendations for omeprazole, lansoprazole,…